Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOSTON-3: Extension Study of Liposomal Cyclosporine A for Bronchiolitis Obliterans in Lung Transplant Recipients
NCT04039347Phase 3Terminated
- Sponsor
- Zambon
- Start
- Mar 2020
- Primary completion
- Feb 2026
- Modality
- Peptides, Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of liposomal cyclosporine A in Bronchiolitis Obliterans Syndrome (BOS), sponsored by Zambon. Started Mar 2020; status: terminated.
02
Drugs
liposomal cyclosporine A
03
Conditions
Bronchiolitis Obliterans Syndrome (BOS)
Beyond the preview
Go deeper on NCT04039347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04039347.